Regulated Information

Filter

Period

Filter by

recent search

Showing: 1 – 05 of 114 Regulated Information

IPSEN - Buy-back program - Art 5 of MAR - Week 42 - 2023
IPSEN – Buy-back program – Art 5 of MAR – Week 42 – 2023

Aggregated presentation by day and by market


Ipsen updates on E.U. Marketing Authorisation Application for odevixibat in Alagille syndrome
Ipsen updates on E.U. Marketing Authorisation Application for odevixibat in Alagille syndrome

PARIS, FRANCE, 23 October 2023 – Ipsen (Euronext: IPN: ADR: IPSEY) today announced that the European Medicines Agency’s (EMA) Committee for Orphan Medicinal Products (COMP) confirmed its negative opinion recommending not to maintain the orphan designation for Bylvay® (odevixibat) in…


IPSEN - Buy-back programme - Art 5 of MAR - Week 41 - 2023
IPSEN – Buy-back programme – Art 5 of MAR – Week 41 – 2023

Aggregated presentation by day and by market


IPSEN - Buy-back programme - Art 5 of MAR - Week 40 - 2023
IPSEN – Buy-back programme – Art 5 of MAR – Week 40 – 2023

Aggregated presentation by day and by market


IPSEN - Buy-back programme - Art 5 of MAR - Week 39 - 2023
IPSEN – Buy-back programme – Art 5 of MAR – Week 39 – 2023

Aggregated presentation by day and by market


1 2 3 4 5 23